Sinem Nalbantoglu
Overview
Explore the profile of Sinem Nalbantoglu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
39
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nalbantoglu S, Karadag A
J Pharm Biomed Anal
. 2021 Apr;
199:114031.
PMID: 33857836
Systems biology adopted functional and integrative multiomics approaches enable to discover the whole set of interacting regulatory components such as genes, transcripts, proteins, metabolites, and metabolite dependent protein modifications. This...
2.
Kara A, Ozgur A, Nalbantoglu S, Karadag A
Mol Biol Rep
. 2021 Apr;
48(4):3813-3825.
PMID: 33856604
Lung cancer is the leading cancer type of death rate. The lung adenocarcinoma subtype is responsible for almost half of the total lung cancer deaths. Despite the improvements in cancer...
3.
Nalbantoglu S, Abu-Asab M, Suy S, Collins S, Amri H
OMICS
. 2019 Apr;
23(4):214-223.
PMID: 31009330
Metabolomics offers new promise for research on prostate cancer (PCa) and its personalized treatment. Metabolomic profiling of radiation-treated PCa patients is particularly important to reveal their new metabolomic status, and...
4.
Ozdemirkiran F, Nalbantoglu S, Gokgoz Z, Payzin B, Vural F, Cagirgan S, et al.
Arch Med Sci
. 2017 Mar;
13(2):426-432.
PMID: 28261298
Introduction: Chronic myeloproliferative disorders (CMPD) are chronic myeloid hematological disorders, characterized by increased myeloid cell proliferation and fibrosis. Impaired apoptotic mechanisms, increased cell proliferation, uncontrolled hematopoietic cell proliferation and myeloaccumulation...
5.
Nalbantoglu S, Abu-Asab M, Tan M, Zhang X, Cai L, Amri H
OMICS
. 2016 Jul;
20(7):442-7.
PMID: 27428255
Pancreatic ductal adenocarcinoma (PDAC) is one of the rapidly growing forms of pancreatic cancer with a poor prognosis and less than 5% 5-year survival rate. In this study, we characterized...
6.
Nalbantoglu S, Tabel Y, Mir S, Berdeli A
Cytokine
. 2013 Mar;
62(1):160-4.
PMID: 23523092
Henoch-Schönlein purpura (HSP) is a small-vessel vasculitis of autoimmune hypersensitivity with rash, arthritis, abdominal pain and renal involvements. Macrophage migration inhibitory factor (MIF) is a immunoregulatory proinflammatory cytokine, and a...
7.
Nalbantoglu S, Tabel Y, Mir S, Serdaroglu E, Berdeli A
Dis Markers
. 2012 Nov;
34(1):23-32.
PMID: 23151617
Henoch-Schönlein purpura (HSP) is a small-vessel vasculitis of autoimmune hypersensitivity, and renin-angiotensin system (RAS) regulates vascular homeostasis and inflammation with activation of cytokine release. Thus, we aimed to investigate the...
8.
Berdeli A, Mir S, Nalbantoglu S, Kutukculer N, Sozeri B, Kabasakal Y, et al.
Genet Test Mol Biomarkers
. 2011 Mar;
15(7-8):475-82.
PMID: 21413889
Familial Mediterranean fever (FMF) is a hereditary autoinflammatory disorder characterized by episodes of inflammation in the absence of high-titer autoantibodies or antigen-specific T cells. The Mediterranean fever (MEFV) gene located...